TABLE 1.
Oligonucleotides used in this study
| Oligonucleotide | Sequence (length of oligonucleotide) |
|---|---|
| 18mer-M13 | 5′–TTTTTTTTTTTTTTTTTTTTCAGGGTTTTCCCAGTCAC–3′ (38 nt) |
| 39mer-M13 | 5′–TTTTTTTTTTTTTTTTTTTTGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGAC–3′ (59 nt) |
| 39mer40dTM13 | 5′–TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGAC–3′ (79 nt) |
| D50 | 5′–GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCAGGCACCCGATGGC–3′ (50 nt) |
| D75E | 5′–GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCTAGCATATGCTAGCCCGCTGCGGCCAGGCACCCGATGGC–3′ (75 nt) |
| D74 | 5′–GGGACGCGTCGGCCTGGCACGTCGGCCGCTGCGGCCAGGCACCCGATGGCGTTTGTTTGTTTGTTTGTTTGTTT–3′ (74 nt) |
| D50-5′ | 5′–CCGCTGCGGCCAGGCACCCGATGGCGGGACGCGTCGGCCTGGCACGTCGG–3′ (50 nt) |
| D55 | 5′–CCGACGTGCCAGGCCGACGCGTCCCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTT–3′ (55 nt) |
| D25 | 5′–GCCATCGGGTGCCTGGCCGCAGCGG–3′ (25 nt) |
| D25F | 5′–CCGACGTGCCAGGCCGACGCGTCCC–3′ (25 nt) |
| G49 | 5′–GCCATCGGGTGCCTGGCCGCAGCGGTTTGTTTGTTTGTTTGTTTGTTTG–3′ (49 nt) |
| G45 | 5′–CATATGCTAGGCCGCAGCGGCCGACGTGCCAGGCCGACGCGTCCC–3′ (45 nt) |
| G40 | 5′–GCTAGGCCGCAGCGGCCGACGTGCCAGGCCGACGCGTCCC–3′ (40 nt) |
| 729 | 5′–CGAACAATTCAGCGGCTTTAACCGGACGCTCGACGCCATTAATAATGTTTTC–3′ (52 nt) |
| 5TY-1 | 5′–GAAAACATTATTAATGGCGTCGAGCTAGGCACAAGGCGAACTGCTAACGG–3′ (50 nt) |
| 5TBG | 5′–CCGTTAGCAGTTCGCCTTGTGCCTAG–3′ (26 nt) |